An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy's ability to trigger an immune response against cancer, Weill Cornell Medicine scientists found in a new study.
Cornell and IBM announced a joint research project June 23 that will use genetic sequencing and big-data analyses to help keep the global milk supply safe.
The first-ever 'disease in a Petri dish' platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease.
A calcium-dependent molecular mechanism discovered in the brain cells of mice by Weill Cornell Medicine investigators may underlie the impaired social interactions and anxiety found in neuropsychiatric disorders – including schizophrenia and autism.
The Clinical and Translational Science Center, in collaboration with the medical student group Tech-in-Medicine, hosted its first hackathon, the 3-D Printing Innovation Challenge, over the course of several days in May.
Cornell and Ludwig Institute for Cancer Research scientists have developed a way to produce a protein antigen that may be used as a vaccine for the tropical disease schistosomiasis.
The Atkinson Center for a Sustainable Future's Academic Venture Fund awarded $1.8 million in 2017, with 15 grants to seed novel approaches to some of the world's greatest sustainability challenges.
Fascinating science is being done at the New York State Agricultural Experiment Station (NYSAES), and student researchers are eager to share their work June 23 from 9 a.m. to 3:30 p.m. at Jordan Hall.
Jacqueline Davis-Manigaulte '72 won the 2017 National Urban Extension Leadership Award for excellence in urban extension programming and leadership for her Cornell University Cooperative Extension-New York City work.
